Correlation Between Ionis Pharmaceuticals and Alnylam Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Ionis Pharmaceuticals and Alnylam Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ionis Pharmaceuticals and Alnylam Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ionis Pharmaceuticals and Alnylam Pharmaceuticals, you can compare the effects of market volatilities on Ionis Pharmaceuticals and Alnylam Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ionis Pharmaceuticals with a short position of Alnylam Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ionis Pharmaceuticals and Alnylam Pharmaceuticals.
Diversification Opportunities for Ionis Pharmaceuticals and Alnylam Pharmaceuticals
0.09 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Ionis and Alnylam is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Ionis Pharmaceuticals and Alnylam Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alnylam Pharmaceuticals and Ionis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ionis Pharmaceuticals are associated (or correlated) with Alnylam Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alnylam Pharmaceuticals has no effect on the direction of Ionis Pharmaceuticals i.e., Ionis Pharmaceuticals and Alnylam Pharmaceuticals go up and down completely randomly.
Pair Corralation between Ionis Pharmaceuticals and Alnylam Pharmaceuticals
Given the investment horizon of 90 days Ionis Pharmaceuticals is expected to generate 0.86 times more return on investment than Alnylam Pharmaceuticals. However, Ionis Pharmaceuticals is 1.17 times less risky than Alnylam Pharmaceuticals. It trades about -0.22 of its potential returns per unit of risk. Alnylam Pharmaceuticals is currently generating about -0.19 per unit of risk. If you would invest 4,036 in Ionis Pharmaceuticals on August 27, 2024 and sell it today you would lose (490.00) from holding Ionis Pharmaceuticals or give up 12.14% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ionis Pharmaceuticals vs. Alnylam Pharmaceuticals
Performance |
| Timeline |
| Ionis Pharmaceuticals |
| Alnylam Pharmaceuticals |
Ionis Pharmaceuticals and Alnylam Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ionis Pharmaceuticals and Alnylam Pharmaceuticals
The main advantage of trading using opposite Ionis Pharmaceuticals and Alnylam Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ionis Pharmaceuticals position performs unexpectedly, Alnylam Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alnylam Pharmaceuticals will offset losses from the drop in Alnylam Pharmaceuticals' long position.| Ionis Pharmaceuticals vs. Arrowhead Pharmaceuticals | Ionis Pharmaceuticals vs. Biomarin Pharmaceutical | Ionis Pharmaceuticals vs. Incyte | Ionis Pharmaceuticals vs. Apellis Pharmaceuticals |
| Alnylam Pharmaceuticals vs. ProQR Therapeutics BV | Alnylam Pharmaceuticals vs. Wave Life Sciences | Alnylam Pharmaceuticals vs. Blueprint Medicines Corp | Alnylam Pharmaceuticals vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |